MarkEdwardHatleyMDPhD
Pediatric Hematology & Oncology • Memphis, TNPediatric Sarcoma Oncology, Pediatric Solid Tumor Oncology
Associate Member, St. Jude Children's Research Hospital
Dr. Hatley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
St. Jude Children's Research Hospital
262 Danny Thomas Place
Memphis, TN 38105- Is this information wrong?
Summary
- Dr. Mark Hatley is a pediatric hematologist/oncologist and scientist. Dr. Hatley is the Director of the Molecular Oncology Division at St. Jude Children's Research Hospital in Memphis, TN. He received his medical degree from University of Texas Southwestern Medical School and has been in practice 13 years. He specializes in pediatric sarcoma oncology and is experienced in sarcomas, molecular biology, and sarcoma biology.
Education & Training
University of Texas Southwestern Medical CenterFellowship, Pediatric Hematology/Oncology, 2006 - 2010- University of Texas Southwestern Medical CenterResidency, Pediatrics, 2004 - 2006
University of Texas Southwestern Medical SchoolClass of 2004
Certifications & Licensure
TN State Medical License 2012 - 2025
TX State Medical License 2009 - 2012- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Member American Pediatric Society, 2023
- Member American Society of Clinical Investigation, 2020
- Member Society for Pediatric Research, 2020
- Join now to see all
Publications & Presentations
PubMed
- Histone lysine demethylase 4 family proteins maintain the transcriptional program and adrenergic cellular state of MYCN-amplified neuroblastoma.Ahmed Abu-Zaid, Jie Fang, Hongjian Jin, Shivendra Singh, Prahalathan Pichavaram, Qiong Wu, Heather Tillman, Laura Janke, Wojciech Rosikiewicz, Beisi Xu, Lee-Ann Van De...> ;Cell Reports. Medicine. 2024 Mar 19
- PAX3-FOXO1 dictates myogenic reprogramming and rhabdomyosarcoma identity in endothelial progenitors.Madeline B Searcy, Randolph K Larsen 4th, Bradley T Stevens, Yang Zhang, Hongjian Jin, Catherine J Drummond, Casey G Langdon, Katherine E Gadek, Kyna Vuong, Kristin B ...> ;Nature Communications. 2023 Nov 15
- Author Correction: Proteasome inhibition targets the KMT2A transcriptional complex in acute lymphoblastic leukemia.Jennifer L Kamens, Stephanie Nance, Cary Koss, Beisi Xu, Anitria Cotton, Jeannie W Lam, Elizabeth A R Garfinkle, Pratima Nallagatla, Amelia M R Smith, Sharnise Mitchel...> ;Nature Communications. 2023 Mar 9
- Join now to see all
Press Mentions
Four Young Pediatric Cancer Research Fellows Earn Nearly $1 Million in AwardsJuly 16th, 2019
From the Cloud to the Clinic, Wide Range of St. Jude Research Presented at AACR 2018April 12th, 2018
Rhabdomyosarcoma Cell Origin Affects Treatment and Survival of Pediatric PatientsFebruary 8th, 2018- Join now to see all
Grant Support
- Mediators of arrested differentiation in pediatric rhabdomyosarcomaNational Cancer Institute (NCI), NIH2021–2026
- Defining the non-myogenic origins of pediatric rhabdomyosarcomaNational Cancer Institute (NCI), NIH2017–2023
- Dissection of RAS pathway and PTEN loss in rhabdomyosarcomaV Foundation for Cancer Research2016–2018
Professional Memberships
- Member
- American Society for Clinical InvestigationMember
- American Pediatric SocietyMember
- Society for Pediatric ResearchMember
- Children's Oncology GroupMember
Hospital Affiliations
St. Jude Children's Research HospitalMemphis, Tennessee- St. Jude Children's Research HospitalMemphis, Tennessee
External Links
- Hatley Labhttps://www.stjude.org/research/labs/hatley-lab.html
- Hatley Biohttps://www.stjude.org/hatley
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
